DEXCOM INCDXCM

Market cap

$25.8B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	76	100	160	259	402	573	719	1,032	1,476	1,927	2,449	2,910	3,622	4,033
Revenue growth (%)	-
Cost of revenue	40	53	60	83	124	195	226	368	545	647	768	1,027	1,333	1,595
Gross profit	36	47	100	176	278	378	492	664	932	1,280	1,681	1,883	2,289	2,438
Gross margin (%)
Research & development	31	40	45	69	138	156	185	200	274	360	517	484	506	552
Selling, general & administrative	50	63	84	128	198	286	349	433	516	621	811	1,000	1,185	1,286
Operating margin (%)
Operating income	-45	-56	-29	-21	-57	-64	-42	-186	142	300	266	391	598	600
Operating expenses	81	102	129	198	336	442	535	850	789	981	1,415	1,492	1,691	1,838
Income before tax	-	-56	-30	-22	-57	-65	-49	-126	104	225	174	391	710	709
Pretax margin (%)	-	-55.9	-18.6	-8.6	-14.3	-11.3	-6.8	-12.3	7.1	11.7	7.1	13.4	19.6	17.6
Provision for income taxes	-	-1	-	0	0	1	2	1	3	-269	19	50	169	133
Effective tax rate (%)	-		-
Net income	-45	-54	-30	-22	-58	-66	-50	-127	101	494	155	341	542	576
Net income margin (%)
Earnings per share	-	-	-	-	-	-	-	-	1.11	5.23	1.6	0.88	1.4	1.46
Diluted EPS	-	-	-	-	-	-	-	-	1.1	5.06	1.55	0.82	1.3	1.42
EBITDA
EBITDA margin (%)